Healthcare robotics: Reasons why this sector will be 'explosive'

clock • 2 min read

The disruptive industries of robotics, automation and artificial intelligence have come to the fore over recent years, with headlines commonplace, including driverless cars reducing road accidents, intelligent fridges doing your shopping and robots increasing crop yields.

But it is in healthcare where robotics and automation could bring some of the most interesting benefits to both society and investors. A recent report on the current state of the healthcare robotics market indicated the growth to come is predicted to be explosive: the current market of $4.1bn is expected to reach $13.9bn by 2023. What may be even more surprising is that, historically, analysts have far underestimated the true growth potential for the medical robotics market. AXA IM unveils global Robotech fund Just look at Intuitive Surgical - in 2003, analysts called the compa...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Specialist

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

‘Dedicated specialists’

James Baxter-Derrington
clock 06 April 2023 • 4 min read
European private equity yet to spend €270bn worth of capital

European private equity yet to spend €270bn worth of capital

Deployment of capital expected

Kathleen Gallagher
clock 04 January 2023 • 1 min read
Early-stage biopharma: An opportunity for strategic investment

Early-stage biopharma: An opportunity for strategic investment

Disproportionately smaller investment

Ali H. Munawar
clock 10 August 2022 • 4 min read
Trustpilot